281 related articles for article (PubMed ID: 24672316)
21. Efficacy comparison of Accell Evo3 and Grafton demineralized bone matrix putties against autologous bone in a rat posterolateral spine fusion model.
Brecevich AT; Kiely PD; Yoon BV; Nguyen JT; Cammisa FP; Abjornson C
Spine J; 2017 Jun; 17(6):855-862. PubMed ID: 28126356
[TBL] [Abstract][Full Text] [Related]
22. Novel spinal instrumentation to enhance osteogenesis and fusion: a preliminary study.
MacEwan MR; Talcott MR; Moran DW; Leuthardt EC
J Neurosurg Spine; 2016 Sep; 25(3):318-27. PubMed ID: 27081709
[TBL] [Abstract][Full Text] [Related]
23. Experimental posterolateral spinal fusion with porous ceramics and mesenchymal stem cells.
Cinotti G; Patti AM; Vulcano A; Della Rocca C; Polveroni G; Giannicola G; Postacchini F
J Bone Joint Surg Br; 2004 Jan; 86(1):135-42. PubMed ID: 14765881
[TBL] [Abstract][Full Text] [Related]
24. Novel Approaches Guiding the Future of Spinal Biologics for Bone Regeneration.
Phan EN; Hsu WK
Curr Rev Musculoskelet Med; 2022 Jun; 15(3):205-212. PubMed ID: 35435574
[TBL] [Abstract][Full Text] [Related]
25. GEORG-SCHMORL-PRIZE OF THE GERMAN SPINE SOCIETY (DWG) 2016: Comparison of in vitro osteogenic potential of iliac crest and degenerative facet joint bone autografts for intervertebral fusion in lumbar spinal stenosis.
Geurts J; Ramp D; Schären S; Netzer C
Eur Spine J; 2017 May; 26(5):1408-1415. PubMed ID: 28324211
[TBL] [Abstract][Full Text] [Related]
26. Graft Materials and Biologics for Spinal Interbody Fusion.
D'Souza M; Macdonald NA; Gendreau JL; Duddleston PJ; Feng AY; Ho AL
Biomedicines; 2019 Sep; 7(4):. PubMed ID: 31561556
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells expressing baculovirus-engineered BMP-2 and VEGF enhance posterolateral spine fusion in a rabbit model.
Fu TS; Chang YH; Wong CB; Wang IC; Tsai TT; Lai PL; Chen LH; Chen WJ
Spine J; 2015 Sep; 15(9):2036-44. PubMed ID: 25463976
[TBL] [Abstract][Full Text] [Related]
28. Current Updates on Bone Grafting Biomaterials and Recombinant Human Growth Factors Implanted Biotherapy for Spinal Fusion: A Review of Human Clinical Studies.
Li G; Li P; Chen Q; Thu HE; Hussain Z
Curr Drug Deliv; 2019; 16(2):94-110. PubMed ID: 30360738
[TBL] [Abstract][Full Text] [Related]
29. Biologics in spine arthrodesis.
Kannan A; Dodwad SN; Hsu WK
J Spinal Disord Tech; 2015 Jun; 28(5):163-70. PubMed ID: 25978141
[TBL] [Abstract][Full Text] [Related]
30. An update on bone substitutes for spinal fusion.
Miyazaki M; Tsumura H; Wang JC; Alanay A
Eur Spine J; 2009 Jun; 18(6):783-99. PubMed ID: 19280232
[TBL] [Abstract][Full Text] [Related]
31. Molecular methods of enhancing lumbar spine fusion.
Sheehan JP; Kallmes DF; Sheehan JM; Jane JA; Fergus AH; diPierro CG; Simmons NE; Makel DD; Helm GA
Neurosurgery; 1996 Sep; 39(3):548-54. PubMed ID: 8875485
[TBL] [Abstract][Full Text] [Related]
32. Bone graft alternatives for spinal fusion.
Grauer JN; Beiner JM; Kwon BK; Vaccaro AR
BioDrugs; 2003; 17(6):391-4. PubMed ID: 14614762
[TBL] [Abstract][Full Text] [Related]
33. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions.
Cook SD; Dalton JE; Tan EH; Whitecloud TS; Rueger DC
Spine (Phila Pa 1976); 1994 Aug; 19(15):1655-63. PubMed ID: 7973957
[TBL] [Abstract][Full Text] [Related]
34. The osteoinductive properties of Nell-1 in a rat spinal fusion model.
Lu SS; Zhang X; Soo C; Hsu T; Napoli A; Aghaloo T; Wu BM; Tsou P; Ting K; Wang JC
Spine J; 2007; 7(1):50-60. PubMed ID: 17197333
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal Stem Cells for the Treatment of Spinal Arthrodesis: From Preclinical Research to Clinical Scenario.
Salamanna F; Sartori M; Brodano GB; Griffoni C; Martini L; Boriani S; Fini M
Stem Cells Int; 2017; 2017():3537094. PubMed ID: 28286524
[TBL] [Abstract][Full Text] [Related]
36. Demineralized bone matrix and spinal arthrodesis.
Lee KJ; Roper JG; Wang JC
Spine J; 2005; 5(6 Suppl):217S-223S. PubMed ID: 16291116
[TBL] [Abstract][Full Text] [Related]
37. Effects of fibronectin on osteoinductive capability of fresh iliac bone marrow aspirate in posterolateral spinal fusion in rabbits.
Koga A; Tokuhashi Y; Ohkawa A; Nishimura T; Takayama K; Ryu J
Spine (Phila Pa 1976); 2008 May; 33(12):1318-23. PubMed ID: 18496343
[TBL] [Abstract][Full Text] [Related]
38. Vascularized Bone Grafts for Spinal Fusion-Part 3: The Occiput.
Bohl MA; Reece EM; Farrokhi F; Davis MJ; Abu-Ghname A; Ropper AE
Oper Neurosurg (Hagerstown); 2021 Apr; 20(5):502-507. PubMed ID: 33609121
[TBL] [Abstract][Full Text] [Related]
39. Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract.
Silcox DH; Boden SD; Schimandle JH; Johnson P; Whitesides TE; Hutton WC
Spine (Phila Pa 1976); 1998 Feb; 23(3):291-6; discussion 297. PubMed ID: 9507615
[TBL] [Abstract][Full Text] [Related]
40. Carrier materials for spinal fusion.
Kwon B; Jenis LG
Spine J; 2005; 5(6 Suppl):224S-230S. PubMed ID: 16291117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
